Dr. Anthony John Defranzo Jr., MD

Dr. Defranzo practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Defranzo's NPI, 1073598017, was assigned on December 13, 2005. Dr. Defranzo graduated from George Washington University School of Medicine in 1973. Dr. Defranzo holds North Carolina license 25128.

Dr. Defranzo's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Defranzo's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Defranzo is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Defranzo to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Defranzo practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Defranzo's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Defranzo is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Defranzo is licensed in North Carolina.

CMS data shows 180 Medicare services from Dr. Defranzo across 4 procedure codes in 2024, for 146 Medicare patients. Medicare paid $6,571 for them.

CMS counts 146 Medicare patients who saw Dr. Defranzo in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Defranzo's median patient age at 72, with 65% women.

In 2024, Dr. Defranzo wrote 65 Medicare Part D claims for 44 patients. 88% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $495 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

Dr. Defranzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of removal or shaving of skin growth by Dr. Defranzo, more than 78% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Defranzo, published from 2011 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Negative-Pressure Wound Therapy and Breast Implantation. Dr. Defranzo has published most often in Ann Plast Surg. Dr. Defranzo's most frequent co-authors are Malcolm Wernick Marks, MD, Ivo Alexander Pestana, MD and Louis C. Argenta, MD.

CMS Open Payments shows 36 general payments to Dr. Defranzo from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Becton, Dickinson and Company paid the most, $2,510.

Dr. Defranzo graduated from George Washington University School of Medicine in 1973.